Parkinson's disease patients and advocates are marking Friday as the start of a new era for treatment of the illness as a ...

Current FDA approval of this adaptive system is for the treatment of Parkinson’s only, not essential tremor, dystonia (a ...

Professor Karlo Malaga leads research focusing on pinpointing specific areas in the subthalamic region where deep brain ...

It's an honor to be a part of this process to, as a basic scientist, be able to play a small role in improving the lives of ...

Penn State Health Milton S. Hershey Medical Center is Pennsylvania's first hospital to offer BrainSense adaptive deep brain ...

The Italian neuromodulation startup Newronika has secured a European approval for its closed-loop, adaptive implant for ...

Twenty-eight years later, as a political science professor emeritus at Stanford, Krehbiel just became the first person in the ...

The Parkinson's Foundation says that nearly one million people in the United States live with the disease, and around 90,000 ...

An update to the traditional deep brain stimulation device enables adaptive pulses of electricity that help to lessen the symptoms of Parkinson’s disease and inform future research.

A new study led by a Bucknell biomedical engineering professor has identified key insights into optimizing deep brain stimulation for Parkinson’s disease patients to help alleviate symptoms such as ...

Newronika announced today that it received CE mark approval for its AlphaDBS device for treating Parkinson's disease.

Newronika, a leader in neuromodulation and adaptive deep brain stimulation (DBS) technology, announced today that it has ...